What not to learn from a meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
http://www.nature.com/articles/nrneph.2009.28.pdf
Reference7 articles.
1. Ruggenenti, P., Noris, M. & Remuzzi, G. Thrombotic microangiopathies. In Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney 3rd edn (ed. Wilcox, C. S.) 294–312 (Saunders, Philadelphia, 2008).
2. Michael, M., Elliott, E. J., Craig, J. C., Ridley, G. & Hodson, E. M. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am. J. Kidney Dis. 53, 259–272 (2008).
3. Ruggenenti, P., Galbusera, M., Cornejo, R. P., Bellavita, P. & Remuzzi, G. Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the disease. Am. J. Kidney Dis. 21, 314–318 (1993).
4. Davin, J. C., Strain, L. & Goodship, T. H. Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation. Pediatr. Nephrol. 23, 1517–1521 (2008).
5. Nathanson, S., Frémeaux-Bacchi, V. & Deschênes, G. Successful plasma therapy in the hemolytic uremic syndrome with factor H deficiency. Pediatr. Nephrol. 16, 554–556 (2001).
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice;Transfusion and Apheresis Science;2020-12
2. Deficiency of CFHR plasma proteins and autoantibody positive hemolytic uremic syndrome: treatment rationale, outcomes, and monitoring;Pediatric Nephrology;2020-06-12
3. Eculizumab for the treatment of hemolytic paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and refractory myasthenia gravis;Expert Opinion on Orphan Drugs;2017-03-24
4. Síndrome hemolítico urémico como forma de presentación de cáncer de próstata diseminado;Nefrología;2016-03
5. Advanced prostate cancer presented with hemolytic uremic syndrome;Nefrología (English Edition);2016-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3